MOMS3: Follow-up in the Teen and Young Adult Years to the Management of Myelomeningocele Study
Published on in CHOP News
Phase three of the Management of Myelomeningocele Study (MOMS), known as “MOMS3,” is a study monitoring the health outcomes of participants ages15-24.